International Clinical Trial: TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987123) titled 'TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial' on May 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Sun Yat-sen University

Condition: Nasopharyngeal Carcinoma (NPC)

Intervention: Drug: Toripalimab Drug: Capecitabine

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: May 18, 2025

Target Sample Size: 62

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06987123

D...